U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C27H26N6O3
Molecular Weight 482.5337
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Enrupatinib

SMILES

COC1=CC(NC2=CC=C3N=CC(=NC3=C2C#N)N4CCOCC4)=CC=C1OCC5=CC=C(C)N=C5

InChI

InChIKey=UGKFKFGVNJJPOL-UHFFFAOYSA-N
InChI=1S/C27H26N6O3/c1-18-3-4-19(15-29-18)17-36-24-8-5-20(13-25(24)34-2)31-22-6-7-23-27(21(22)14-28)32-26(16-30-23)33-9-11-35-12-10-33/h3-8,13,15-16,31H,9-12,17H2,1-2H3

HIDE SMILES / InChI

Molecular Formula C27H26N6O3
Molecular Weight 482.5337
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 01:16:16 GMT 2025
Edited
by admin
on Wed Apr 02 01:16:16 GMT 2025
Record UNII
9L35RVQ9J6
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
Enrupatinib
INN  
Official Name English
EI-1071
Preferred Name English
enrupatinib [INN]
Common Name English
EI1071
Code English
Code System Code Type Description
INN
13274
Created by admin on Wed Apr 02 01:16:16 GMT 2025 , Edited by admin on Wed Apr 02 01:16:16 GMT 2025
PRIMARY
FDA UNII
9L35RVQ9J6
Created by admin on Wed Apr 02 01:16:16 GMT 2025 , Edited by admin on Wed Apr 02 01:16:16 GMT 2025
PRIMARY
SMS_ID
300000056615
Created by admin on Wed Apr 02 01:16:16 GMT 2025 , Edited by admin on Wed Apr 02 01:16:16 GMT 2025
PRIMARY
PUBCHEM
134442338
Created by admin on Wed Apr 02 01:16:16 GMT 2025 , Edited by admin on Wed Apr 02 01:16:16 GMT 2025
PRIMARY
CAS
2222689-47-4
Created by admin on Wed Apr 02 01:16:16 GMT 2025 , Edited by admin on Wed Apr 02 01:16:16 GMT 2025
PRIMARY
NCI_THESAURUS
C211750
Created by admin on Wed Apr 02 01:16:16 GMT 2025 , Edited by admin on Wed Apr 02 01:16:16 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Selective exhibited nanomolar potency for inhibition of CSF-1R but not other 453 kinases tested.
BINDER->LIGAND
BINDING
METABOLIC ENZYME -> INHIBITOR
Testosterone substrate
IC50
METABOLIC ENZYME -> INHIBITOR
MIDAZOLAM substrate
IC50
Related Record Type Details
ACTIVE MOIETY